COMMUNIQUÉS West-GlobeNewswire

XBiotech Announces New Patents for Third Quarter 2018
26/10/2018
Patents Granted/Allowed for Company’s Candidate Treatments for Cardiovascular Disease, Staphylococcus Aureus Infections and its Antibody Discovery Technology AUSTIN, Texas, Oct. 26, 2018 (GLOBE NEWSWIRE) -- XBiotech Inc [...]
Sharecare to join Governor Nathan Deal, Walmart, BlueCross BlueShield of Georgia and Emory Healthcare for announcement about improving health of Georgia’s workforce
26/10/2018
ATLANTA, Oct. 26, 2018 (GLOBE NEWSWIRE) -- Sharecare founder Jeff Arnold will join Georgia Governor Nathan Deal and leaders from the Georgia Department of Community Health, Walmart, BlueCross BlueShield of Georgia and [...]
Aeglea BioTherapeutics to Present Preclinical Data on a New Pipeline Therapeutic for Cystinuria in an Oral Presentation at the 2018 American Society of Nephrology (ASN) Annual Meeting
26/10/2018
AEB5100 is an Engineered Human Enzyme with Novel Cystine Degrading Activity Presentation Today at 5:54 p.m. PT at the 2018 American Society of Nephrology (ASN) Annual Meeting AUSTIN, Texas, Oct. 26, 2018 (GLOBE NEWSWIRE [...]
Ultragenyx Announces Negative Topline Results from Phase 3 Study of UX007 in Patients with Glut1 DS with Disabling Movement Disorders
26/10/2018
Ultragenyx discontinuing development of UX007 in Glut1 DS indication Company on track with separate UX007 program in LC-FAOD with pre-NDA meeting later this year NOVATO, Calif., Oct. 26, 2018 (GLOBE NEWSWIRE) -- [...]
Media Advisory: Unlocking the Potential of the Health and Life Sciences Sector
26/10/2018
OTTAWA, Oct. 26, 2018 (GLOBE NEWSWIRE) -- Canada’s Hospital CEOs and Vice-Presidents of health research will join Paul-Émile Cloutier, President and CEO of HealthCare CAN – the national voice of Canadas healthcare [...]
Eidos Therapeutics Receives Positive Opinion for Orphan Designation from the European Medicines Agency for AG10, a Potent Oral Stabilizer for the Treatment of Transthyretin Amyloidosis
26/10/2018
SAN FRANCISCO, Oct. 26, 2018 (GLOBE NEWSWIRE) -- Eidos Therapeutics, Inc. (Eidos) (Nasdaq:EIDX), announced today that the Committee for Orphan Medicinal Products (COMP) within the European Medicines Agency (EMA) adopted [...]
AIT Therapeutics Appoints Douglas J. Beck as Chief Financial Officer
26/10/2018
Seasoned expert with three decades of financial planning and management experience to join AIT Team GARDEN CITY, N.Y., and REHOVOT, Israel, Oct. 26, 2018 (GLOBE NEWSWIRE) -- AIT Therapeutics, Inc. (OTCQB: AITB), a [...]
Melinta Therapeutics to Report Third Quarter 2018 Financial Results on November 7, 2018
26/10/2018
NEW HAVEN, Conn., Oct. 26, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT), a commercial-stage company discovering, developing and commercializing novel antibiotics to treat serious bacterial [...]
Tauriga Sciences Inc. Completes Capital Raise of $168,250 to Support its Merger & Acquisition Activities
26/10/2018
New York, NY, Oct. 26, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. ( TAUG ) (“Tauriga” or the “Company”), engaged in building its business through the development, distribution, and licensing of [...]
VIVUS to Host Third Quarter Business Update and Financial Results Conference Call on Thursday, November 1, 2018
26/10/2018
CAMPBELL, Calif., Oct. 26, 2018 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq: VVUS) today announced that it will report financial results and provide a business update for the third quarter of 2018 after the market close on [...]
HEXO reports fiscal 2018 fourth quarter results
26/10/2018
GATINEAU, Quebec, Oct. 26, 2018 (GLOBE NEWSWIRE) -- HEXO Corp. (TSX:HEXO) (the "Company") reported its financial results for the three and twelve months ended July 31, 2018, the fourth quarter of the 2018 fiscal year. [...]
HEXO annonce ses résultats du quatrième trimestre de l’exercice 2018
26/10/2018
GATINEAU, Québec, 26 oct. 2018 (GLOBE NEWSWIRE) -- HEXO Corp. (TSX:HEXO) (la « Société ») a annoncé ses résultats financiers pour les périodes de trois mois et de douze mois closes le 31 juillet 2018, le quatrième [...]
Aleafia, Serruya Family Extend Exclusivity Period for Retail and Brand Joint-Venture
26/10/2018
Major Adult-Use Retail, Brand JV Backed by Family Behind Iconic Yogen Früz, Second Cup Brands TORONTO, Oct. 26, 2018 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSXV: ALEF; OTCQX: ALEAF, FRA: ARAH) (“Aleafia“) or (the “ [...]
Zealand announces amendments to its Articles of Association following the granting of warrants
26/10/2018
Company announcement - No. 27/2018 Zealand announces amendments to its Articles of Association following the granting of warrants Copenhagen, October 26, 2018 - Zealand Pharma ("Zealand") announces that its Articles of [...]
Opthea Reports Positive Three-Month Data from Phase 1b Dose Escalation Study for OPT-302 in Diabetic Macular Edema
26/10/2018
MELBOURNE, Australia, Oct. 26, 2018 (GLOBE NEWSWIRE) -- Opthea Limited (ASX:OPT), a clinical-stage biopharmaceutical company developing innovative biologic therapies to treat retinal diseases, today announced positive [...]
Data from Clinical and Pre-Clinical Trials Evaluating Verona Pharma’s RPL554 in Cystic Fibrosis Presented at North American Cystic Fibrosis Conference
26/10/2018
Pre-clinical findings show RPL554 stimulates rare class III and IV CFTR mutants Phase 2a results demonstrate RPL554 has favorable pharmacokinetic and pharmacodynamic profile in cystic fibrosis patients LONDON, Oct. 26, [...]
Amarin Schedules Webcast Discussion of Primary REDUCE-IT™ Trial Results Following Presentation at 2018 Scientific Sessions of American Heart Association
26/10/2018
Webcast to Commence at 7:15 p.m. CT / 8:15 p.m. ET, Saturday, November 10, 2018 BEDMINSTER, N.J. and DUBLIN, Ireland, Oct. 26, 2018 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), a pharmaceutical company [...]
Nomination Committee appointed for the 2019 Annual General Meeting in PledPharma
26/10/2018
Stockholm, October 26, 2018 . The Chairman of PledPharma AB has established a Nomination Committee for the Annual General Meeting, which is planned to be held on May 7 2019. The Nomination Committee is composed of [...]
C-RAD AB – Interim report January-September 2018
26/10/2018
Press release 2018-10-26 C-RAD REPORTS ALL-TIME HIGH IN QUARTELY ORDER INTAKE THIRD QUARTER 2018 Order intake: 64.2 (55.5) MSEK, 16%. Revenues: 46.7 (33.2) MSEK, 41%. Operating profit: 0.4 (-1.4) MSEK. Net results after [...]

Pages